Now, at Atara Biotherapeutics, Dr. Touchon guides the development of a host of potentially transformative T-cell immunotherapies for cancer, autoimmune, and viral diseases…

• 
  Presenter

  Peter Hofland, Ph.D

• listen
• read
• share